Sponsored by:
Unlock Faster, More Confident Biosimilar Development
Developing biosimilars requires rigorous analytical characterization to ensure safety, efficacy, and regulatory approval.
This exclusive Sartorius white paper explores how combining Octet® Biolayer Interferometry (BLI) with iQue® High-Throughput Cytometry delivers powerful orthogonal insights into ligand binding kinetics and live-cell functionality.
Inside, you’ll discover:
- How orthogonal techniques streamline biosimilar comparability studies
- Case studies on affinity, kinetics, and live-cell binding assessments
- Practical guidance for reducing variability and enhancing data confidence
- Strategies to accelerate development while meeting stringent regulatory standards
Whether you are in R&D, analytical sciences, or bioprocess development, this resource will help you optimize workflows and improve decision-making in biosimilar development.
